0001757705-21-000002.txt : 20211215
0001757705-21-000002.hdr.sgml : 20211215
20211215115659
ACCESSION NUMBER: 0001757705-21-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20211215
DATE AS OF CHANGE: 20211215
EFFECTIVENESS DATE: 20211215
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Phosplatin Therapeutics Inc.
CENTRAL INDEX KEY: 0001757705
IRS NUMBER: 300635094
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-425067
FILM NUMBER: 211493574
BUSINESS ADDRESS:
STREET 1: 1350 AVENUE OF THE AMERICAS, 3RD FL.
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 646-380-2441
MAIL ADDRESS:
STREET 1: 1350 AVENUE OF THE AMERICAS, 3RD FL.
CITY: NEW YORK
STATE: NY
ZIP: 10019
FORMER COMPANY:
FORMER CONFORMED NAME: Phosplatin Therapeutics LLC
DATE OF NAME CHANGE: 20181031
D
1
primary_doc.xml
X0708
D
LIVE
0001757705
Phosplatin Therapeutics Inc.
1350 AVENUE OF THE AMERICAS
23rd Floor
NEW YORK
NY
NEW YORK
10019
646-380-2441
DELAWARE
Phosplatin Therapeutics LLC
Corporation
true
Robert
Fallon
1350 Avenue of the Americas
23rd Floor
New York
NY
NEW YORK
10019
Executive Officer
Director
Matthew
Price
1350 Avenue of the Americas
23rd Floor
New York
NY
NEW YORK
10019
Director
Rosita
Leong
1350 Avenue of the Americas
23rd Floor
New York
NY
NEW YORK
10019
Director
John
Caouette
1350 Avenue of the Americas
23rd Floor
New York
NY
NEW YORK
10019
Director
Peter
Espig
1350 Avenue of the Americas
23rd Floor
New York
NY
NEW YORK
10019
Director
Frances
Bonham
1350 Avenue of the Americas
23rd Floor
New York
NY
NEW YORK
10019
Executive Officer
Neil
Sunderland
1350 Avenue of the Americas
23rd Floor
New York
NY
NEW YORK
10019
Director
Charles
Stuckey
1350 Avenue of the Americas
23rd Floor
New York
NY
NEW YORK
10019
Director
Elizabeth
Tallett
1350 Avenue of the Americas
23rd Floor
New York
NY
NEW YORK
10019
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2021-12-03
false
true
false
0
37295619
37295619
0
false
41
0
0
0
false
Phosplatin Therapeutics Inc.
Frances Bonham
Frances Bonham
Vice President of Finance and Administration
2021-12-08